Cadaveric renal transplantation under cyclosporine-steroid therapy

Ninety-seven cadaveric renal transplants were performed upon 96 patients during 1981. The one year patient mortality was 2.1 per cent. Seventy of the recipients were undergoing trasplantation for the first time. Of these patients, 38 were treated with cyclosporine and steroids with a one year graft survival rate of 89.5 per cent. The other 32 primary recipients were treated with azathioprine and steroids with a one year graft survival rate of 50 per cent. The difference between the cyclosporine-steroid versus conventional therapy groups was significant. Cyclosporine and steroids were also used to treat 26 patients who underwent retransplantation with 27 cadaveric grafts. The one year graft survival time was 77.8 per cent; most of the graft losses were in presensitized patients. The results with retransplantation were twice as good as in historical control groups

Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids

The postoperative convalescence period was analyzed for 42 consecutive patients who had cadaveric renal transplantation under therapy with cyclosporin A and steroids. Twenty-two of the patients underwent transplantation for the first time, and the other 20 had retransplantation. None of the recipients has died. With follow-up period of two to eight months, the survival rate of grafts is 96 per cent after first transplantation and 85 per cent after retransplantation. Immunosuppression with a standard regimen was used for all patients at the outset. Early convalescence was highly variable, often necessitating adjustments of cyclosporin A and steroid dosage to accommodate the possibilities of rejection or cyclosporin A nephrotoxicity, or both, simultaneously. Management problems were more frequent and complex in patients undergoing retransplantation. From the results, a classification of convalescence patterns was evolved, with recommendations about how standardized initial therapy should be adjusted if the renal graft does not function promptly or deteriorates later

Computationally efficient implementation of hybrid functionals in SIESTA

In this work we have implemented hybrid functionals into the SIESTA code, with the main goal to implement a fast general solver within the SIESTA framework that performs efficiently and scales linearly with increasing system size. We describe the implementation of the solver and apply it to study the properties of five insulating materials; NaCl, CaF2, CeO2, TiO2 and HfO2. We show that a systematic improvement in the basic description of the properties of these materials over standard Density Functional approaches can be obtained at a reasonable additional computational cost

KIC 10449976: discovery of an extreme-helium subdwarf in the Kepler field

Optical spectroscopy of the blue star KIC 10449976 shows that it is an extremely helium-rich subdwarf with effective temperature T=40000+/-300 K and surface gravity log g=5.3+/-0.1. Radial-velocity measurements over a five-day timescale show an upper variability limit of ~50+/-20 km/s. Kepler photometry of KIC 10449976 in both long and short cadence modes shows evidence for a periodic modulation on a timescale of ~3.9 days. We have examined the possibility that this modulation is not astrophysical but conclude it is most likely real. We discuss whether the modulation could be caused by a low-mass companion, by stellar pulsations, or by spots. The identification of any one of these as cause has important consequences for understanding the origin of helium-rich subdwarfs.Comment: Accepted by MNRA

Cadaveric renal transplantation at the University of Pittsburgh: a two and one-half-year experience with the point system.

From January 1, 1986 to July 30, 1988, 530 consecutive cadaver kidney transplantations were performed with patient selection by a point system that took into account time awaiting an organ, donor-recipient matching, degree of presensitization, and some less important factors. The effect of the system was to diminish judgmental factors in case selection which in the past, had probably operated to the disadvantage of "undesirable" potential recipients, including older ones. Primary 1-year graft survival (74%) and graft survival after retransplantation (71%) were lower than in the earlier time. However, the results with triple-drug therapy using CsA, AZA and P demonstrated 88% 1-year graft survival for primary graft recipients and 74% in highly sensitized patients, with comparable patient mortality. These latter observations provide some assurance that the concepts of equitable access and efficient utilization of a scarce resource are not mutually exclusive